July 29, 2013

U.S.-based drug maker Perrigo Co. will buy Ireland's Elan Corp. for $8.6 billion, the companies said.

July 29, 2013

Drug maker Pfizer is planning to split its commercial division into three business lines that will separate its branded and generic products, the company said Monday.

July 29, 2013

Rite Aid is launching a marketing campaign centered around its new extension to the Wellness+ loyalty card program aimed at seniors, the retail pharmacy chain said.

July 26, 2013

Independent pharmacies enrolled in AmerisourceBergen Drug Corp.'s Good Neighbor Pharmacy Business Coaching program have experienced per-employee sales increases of 5% on average, the company said.

July 26, 2013

Anda VP purchasing Marc Falkin wrote in an email to coworkers and friends that he would begin working for Actavis as VP marketing, pricing and contract operations for the Parsippany, N.J.-based drug maker's generics business.

July 26, 2013

A federal court has ruled in favor of generic drug maker Sandoz in a case involving a drug for multiple sclerosis, Sandoz said.

July 26, 2013

Pharmacists at Good Neighbor Pharmacy can provide immunizations to patients without a prescription from a physician under a new program, parent company AmerisourceBergen Drug Corp. said.

July 26, 2013

While rates of human papillomavirus infection among girls ages 14 years to 19 years have dropped by half since the Centers for Disease Control and Prevention started recommending routine vaccination against it seven years ago, rates of vaccination have not increased, the agency said.

July 26, 2013

A new track-and-trace bill that the Senate is expected to consider would institute a nationwide "track-and-trace" system in place of patchwork state laws with the aim of securing the pharmaceutical supply chain.

July 25, 2013

A new program in south Florida will provide health care for children in underserved communities using mobile telemedicine.

July 25, 2013

Mylan and Orion Corp. have settled a patent-infringement suit over a drug used to treat Parkinson's disease.

July 24, 2013

Prior-authorization software company CoverMyMeds reached a milestone Tuesday as the 5 millionth PA request was sent through its system.

July 24, 2013

The Food and Drug Administration has granted the manufacturer of Plan B One-Step exclusive marketing rights for three years, according to published reports.

July 24, 2013

Ahold USA division Giant Food Stores has raised $540,888 for the Children's Miracle Network Hospitals, the chain said Wednesday.

July 24, 2013

Canadian regulators have approved two drugs made by GlaxoSmithKline for treating skin cancer.

July 24, 2013

An increase in tobacco taxes in Minnesota has nearly tripled enrollment in a health plan's smoking-cessation program.

July 24, 2013

Mylan has settled with the makers of a drug used to treat cancer in a patent-infringement lawsuit, the generic drug maker said.

July 24, 2013

Despite widespread doubt and dissatisfaction, most adults say they're not ready to repeal the healthcare-reform law signed into law two years ago by President Obama, according to a poll.

July 23, 2013

A federal court has ruled that a Mylan lawsuit against GlaxoSmithKline over an antidepressant drug can go to trial.

July 23, 2013

The Food and Drug Administration has approved a generic diabetes drug made by Lupin, the company said.

July 23, 2013

The Pharmacy Quality Alliance is supporting medication synchronization programs and pilots at pharmacies around the country using an appointment-based model, saying the model focuses on aligning drug refills of chronic medications to fall upon the same appointment date each month, the group said Tuesday.

July 22, 2013

The Food and Drug Administration has approved a drug made by Japanese drug maker Astellas for preventing the body from rejecting transplanted organs, the company said.

July 22, 2013

A new bill would exempt user fees paid by drug companies to the Food and Drug Administration — including those of generic drug makers — from the automatic federal budget cuts that went into effect in March, commonly known as the sequester.

July 22, 2013

Decisions on whether to bring new generic drugs to market depend significantly on companies' ability to settle patent lawsuits filed by branded drug companies, according to a new white paper.